JRS Specialty Products Facility in China Awarded EXCiPACT Certification


JRS PHARMA is pleased to announce that its Star-Tech & JRS Specialty Products excipients manufacturing site in Chongqing, China, has been awarded EXCiPACT certification.

The certification ensures via third-party inspection, evaluation, and auditing that the facility meets all of EXCiPACT’s criteria for good manufacturing practice (GMP) standards.

Star-Tech & JRS Specialty Products’ state-of-the-art GMP-compliant production facility is the result of a 2016 joint venture between JRS PHARMA and Chinese company, SSP. The site specializes in the manufacture of high-quality povidones for life sciences applications. These products include: 

  • VIVAPHARM® PVP (Povidone), the classic wet binder with optimal balance between adhesive strength and ease of handling.
  • VIVAPHARM® PVP/VA 64 (Copovidone), the ultimate tablet binder for all processing technologies.
  • VIVAPHARM® PVPP (Crospovidone), offering unsurpassed disintegration performance and versatility.


EXCiPACT provides a credible, high-quality, third-party scheme that allows manufacturers, suppliers, and distributors of pharmaceutical excipients worldwide to prove they have adopted best practices within their quality management systems. A not-for-profit organization, EXCiPACT is registered in Brussels, Belgium. 


JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of solutions for the global health science industry. Its excipients portfolio includes: high-functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilizers, carriers, and coatings. In addition to a wide range of excipients, they offer excellent technical support and biopharma services to address the needs and formulation challenges of their customers.

Stay Connected.     LinkedIn  Youtube 

Copyright 2020, JRS PHARMA - All Rights Reserved